Professional Documents
Culture Documents
➢ The Sensex rallied 526.01 points, or 0.73%, to end NASDAQ 16,399.52 +0.51%
at 72,996.31, while the Nifty 50 settled 118.95 NIKKEI 225 40,268.08 -1.21%
points, or 0.54%, higher at 22,123.65.
HANG SENG 16,418.00 +0.15%
➢ US Stock Market: On Wednesday, the US stock market indices closed higher, with the S&P 500
reaching a new record high, anticipating the release of inflation data and commentary from the US
Federal Reserve that would provide insights into its future interest rate decisions.
➢ Asian Markets: On Thursday, Asian markets experienced a downturn, although Australian stocks
reached an all-time high. Japan's Nikkei 225 dropped by 0.98%, and the Topix saw a significant decline
of 1.08%. South Korea's Kospi decreased by 0.19%, while futures for Hong Kong's Hang Seng index
➢ Indian Stock Market On Wednesday, the Indian stock market indices ended with decent gains led by
a rally in index heavyweights, with the benchmark Nifty 50 closing above the 22,100 level.
➢ Gift Nifty: Gift Nifty was hovering around the 22,173 mark, maintaining a premium of approximately
6 points compared to the previous close of Nifty futures. This suggests a neutral opening for the Indian
qualifying for the abbreviated T+0 settlement cycle, effective from today, March 28th. This T+0
settlement option will be voluntary for these 25 stocks and will apply solely to trades conducted
➢ Oil Prices: Crude oil prices climbed, poised for a robust quarterly increase driven by anticipations of
OPEC reducing supplies. West Texas Intermediate increased by 0.49% to $81.75 per barrel following
a slight decline over two days, while Brent crude rose by 0.31% to $86.36.
➢ Dr Reddy’s Laboratories: Dr. Reddy's Laboratories has forged a distribution alliance with Sanofi
Healthcare India Private Limited. Through this partnership, Dr. Reddy's will market and distribute
Sanofi's vaccine brands in India, encompassing established pediatric and adult vaccines, thereby
➢ Zydus Lifesciences: Zydus Lifesciences underwent a cGMP inspection by the USFDA at its
manufacturing facility in Ahmedabad from March 18 to March 27, 2024. The inspection resulted in
➢ Exide Industries: Exide Industries has infused Rs 34.99 crore through subscription into the equity
share capital of its wholly-owned subsidiary, Exide Energy Solutions (EESL), on a rights basis. With
this addition, the Company's total investment in EESL amounts to Rs. 2,000 crore. The acquisition does
➢ Bajaj Finance: According to sources familiar with the matter speaking to NDTV Profit, the non-
banking financial company is considering an initial public offering (IPO) with a potential size of $1
billion. Bajaj Finance is reportedly aiming for a valuation of $10 billion. However, discussions are still
*******************************